Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
36.02
+0.73 (2.07%)
After Hours: 36.02 0.00 (0.00%)
May 4, 4:46PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 34.83 - 36.39
52 week 24.34 - 40.33
Open 34.83
Vol / Avg. 205,837.00/138,980.00
Mkt cap 633.61M
P/E 80.91
Div/yield     -
EPS 0.45
Shares 17.37M
Beta 0.62
Inst. own 80%
Jul 19, 2016
Q2 2016 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 9, 2016
Vascular Solutions Inc at Citi Small and Mid Cap Conference Add to calendar
Apr 29, 2016
Vascular Solutions Inc Annual Shareholders Meeting (Estimated)
Apr 29, 2016
Vascular Solutions Inc Annual Shareholders Meeting
Apr 25, 2016
Q1 2016 Vascular Solutions Inc Earnings Call - Webcast
Apr 25, 2016
Q1 2016 Vascular Solutions Inc Earnings Release
Apr 12, 2016
Vascular Solutions Inc at Needham Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -0.65% 7.11%
Operating margin -2.26% 9.24%
EBITD margin - 13.31%
Return on average assets -0.72% 7.71%
Return on average equity -0.80% 8.67%
Employees 568 -
CDP Score - -

Address

6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vascular Solutions, Inc. is a medical device company, which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products, which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions, such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products, which consist of the D-Stat Dry hemostat to control surface bleeding, D-Stat Flowable for preventing bleeding in subcutaneous pockets, Accumed wrist positioning splints and Vasc Band inflatable compression bands, and Vein products, which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Howard C. Root Chief Executive Officer and Director
Age: 55
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - International Sales
Age: 63
Bio & Compensation  - Reuters
Brent Binkowski Senior Vice President - Operations
Age: 47
Bio & Compensation  - Reuters
Chad Kugler Senior Vice President - Research and Development
Age: 44
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 41
Bio & Compensation  - Reuters
Martin J. Emerson Independent Director
Age: 51
Bio & Compensation  - Reuters
Richard W. Kramp Independent Director
Age: 69
Bio & Compensation  - Reuters
Richard J. Nigon Independent Director
Age: 67
Bio & Compensation  - Reuters